Privia Health Group, Inc. (NASDAQ:PRVA) Receives $30.42 Consensus Price Target from Analysts

Privia Health Group, Inc. (NASDAQ:PRVA) has received a consensus recommendation of “Moderate Buy” from the fifteen research firms that are currently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $30.4167.

Several equities analysts have commented on the stock. Weiss Ratings reissued a “hold (c)” rating on shares of Privia Health Group in a research report on Monday. Stephens reiterated an “overweight” rating and issued a $32.00 price objective on shares of Privia Health Group in a research note on Thursday, December 4th. JPMorgan Chase & Co. lifted their target price on Privia Health Group from $32.00 to $33.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Barclays upped their price target on Privia Health Group from $22.00 to $23.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. Finally, Citizens Jmp increased their price target on Privia Health Group from $30.00 to $31.00 and gave the company a “market outperform” rating in a research report on Friday, November 7th.

Insider Activity at Privia Health Group

In other news, Director Matthew Shawn Morris sold 13,647 shares of the firm’s stock in a transaction on Friday, December 12th. The shares were sold at an average price of $25.01, for a total value of $341,311.47. Following the sale, the director directly owned 68,188 shares in the company, valued at approximately $1,705,381.88. This trade represents a 16.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO David Mountcastle sold 23,887 shares of the business’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $25.03, for a total transaction of $597,891.61. Following the transaction, the chief financial officer owned 172,909 shares of the company’s stock, valued at approximately $4,327,912.27. The trade was a 12.14% decrease in their position. The disclosure for this sale is available in the SEC filing. 10.70% of the stock is owned by company insiders.

Institutional Trading of Privia Health Group

Hedge funds and other institutional investors have recently bought and sold shares of the business. Wealth Alliance LLC boosted its position in shares of Privia Health Group by 4.4% during the 3rd quarter. Wealth Alliance LLC now owns 11,979 shares of the company’s stock worth $298,000 after acquiring an additional 508 shares in the last quarter. Arizona State Retirement System lifted its stake in Privia Health Group by 1.9% during the third quarter. Arizona State Retirement System now owns 28,835 shares of the company’s stock worth $718,000 after purchasing an additional 524 shares during the last quarter. Bank of Montreal Can boosted its holdings in Privia Health Group by 1.9% in the second quarter. Bank of Montreal Can now owns 28,694 shares of the company’s stock valued at $660,000 after purchasing an additional 543 shares in the last quarter. Illinois Municipal Retirement Fund increased its stake in Privia Health Group by 1.1% in the third quarter. Illinois Municipal Retirement Fund now owns 55,501 shares of the company’s stock valued at $1,382,000 after purchasing an additional 585 shares during the last quarter. Finally, PNC Financial Services Group Inc. raised its holdings in Privia Health Group by 9.6% during the third quarter. PNC Financial Services Group Inc. now owns 7,731 shares of the company’s stock worth $193,000 after purchasing an additional 675 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Price Performance

Shares of Privia Health Group stock opened at $23.86 on Wednesday. The stock has a market capitalization of $2.93 billion, a price-to-earnings ratio of 183.55, a price-to-earnings-growth ratio of 4.07 and a beta of 0.83. The business has a 50-day moving average of $24.23 and a 200 day moving average of $22.88. Privia Health Group has a 12 month low of $18.77 and a 12 month high of $26.51.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share (EPS) for the quarter. The business had revenue of $213.61 million for the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. Equities research analysts anticipate that Privia Health Group will post 0.14 earnings per share for the current year.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.